ѻý

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

<ѻý class="mpt-content-deck">— News, features, and commentary about cancer-related issues
MedpageToday
Onco Break over a computer rendering of a cancer cell.

A surgical team at Mayo Clinic Arizona in Phoenix performed the first in an active cancer patient in the U.S. He had lost the ability to speak, swallow, and breathe as a result of treatment for a type of head and neck cancer.

The latest data suggest that 40% of all cancers in people 30 or older arise from . (CA: A Cancer Journal for Clinicians)

A dual immunotherapy regimen allowed more than half of patients with one rectal cancer subtype to that would necessitate use of a colostomy bag. (Vanderbilt University Medical Center)

Preliminary clinical results show that the "E-nose" performed well in detecting lung cancer. (Memorial Sloan Kettering Cancer Center)

Exercise that improves might help long-term survivors of childhood cancer avoid treatment-related heart failure later in life, researchers at the University of Alberta said.

Researchers have begun to uncover clues to the in Gen X, born between 1965 and 1980. (JAMA Network Open)

Preclinical studies suggested that might help improve outcomes in the most common form of liver cancer. (Cell Stem Cell)

Early clinical results with skin-targeted with synthetic hypericin photosensitizer for cutaneous T-cell lymphoma led to "treatment success" in three of the first four patients who completed treatment, Soligenix announced.

The FDA updated industry guidance to help companies about approved or cleared medical products.

Two commonly used markers of prostate cancer risk -- high PSA levels and ≥50% positive biopsy cores -- may help identify within the lowest-risk category. (Mass General Brigham)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined ѻý in 2007.